Recent Quotes
My Watchlist
Indicators
Local Stocks
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exact Sciences Cor (NQ: EXAS )

58.75 +0.28 (+0.48%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,373,523
Open 58.33
Bid (Size) 56.00 (1)
Ask (Size) 58.75 (1)
Prev. Close 58.47
Today's Range 57.92 - 59.51
52wk Range 40.62 - 85.71
Shares Outstanding 171,948,769
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
New Modeling Data Show the Cologuard® Test Has Detected More Than 623,000 Cancers and Precancers Over Past Decade, Saving U.S. Health Care System $22 Billion
From Exact Sciences Corp.
Via Business Wire
9 Health Care Stocks Whale Activity In Today's Session
Via Benzinga

Performance

YTD
-20.36%
-20.36%
1 Month
+19.00%
+19.00%
3 Month
+16.61%
+16.61%
6 Month
-3.64%
-3.64%
1 Year
-30.56%
-30.56%

More News

Read More
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
Via Benzinga
Crude Oil Moves Lower; Moderna Shares Plunge
Via Benzinga
Exposures Fossil Fuels
Exact Sciences Analysts Slash Their Forecasts After Q2 Results
Via Benzinga
Peeling Back The Layers: Exploring Exact Sciences Through Analyst Insights
Via Benzinga
Dow Dips Over 500 Points; ISM Manufacturing PMI Falls In July
Via Benzinga
Topics Stocks
Exposures US Equities
Air Products Posts Upbeat Earnings, Joins Meta, Exact Sciences, Shake Shack, Clearwater Analytics And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Why Exact Sciences, Up 20%, Is 'Coiled To Snap Back' After Quarterly Beat
Via Investor's Business Daily
Exact Sciences (EXAS) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Expert Outlook: Exact Sciences Through The Eyes Of 5 Analysts
Via Benzinga
Exact Sciences Stock Climbs After Strong Q2 Results
Via Benzinga
Exact Sciences Announces Second-Quarter 2024 Results
From Exact Sciences Corp.
Via Business Wire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
FDA Greenlights Guardant Health's Shield Blood Test, Analyst Cautious on Adoption
Via Benzinga
Exposures Product Safety
Goldman Sachs Says Buy These 3 Stocks for Double-Digit Returns
Via InvestorPlace
This Cathie Wood Growth Stock Could Soar by 93%, According to Wall Street
Via The Motley Fool
Exact Sciences schedules second quarter 2024 earnings call
From Exact Sciences Corp.
Via Business Wire
The 3 Best Personalized Medicine Stocks to Buy in July 2024
Via InvestorPlace
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Mainz Biomed’s ColoAlert Potentially Puts It On A Similar Track As Big Name Cancer Screening Stocks
Via News Direct
Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests
Via MarketBeat
Jefferies Says Buy These 3 Stocks for More Than Double-Digit Returns
Via InvestorPlace
Is It Time to Buy May's Worst-Performing Nasdaq Stocks?
Via The Motley Fool
Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.